IL1B and neoplasm: Moreover, GSEA highlighted a significant enrichment of the IL1B response signature in ACP tumours using three independent datasets of genes up-regulated upon IL1B treatment (NES = 1.79, 2.25, 2.66, respectively; FDRs < 0.001) (Fig. 9a).